China Traditional Chinese Medicine Holdings Co. Limited
CHIZFOTCHealthcare● Active
$0.27
+$0.05(+24.87%)
Market Cap$1.4B
P/E Ratio—
52W High$0.3454
52W Low$0.21895
China Traditional Chinese Medicine Holdings Co. Limited（CHIZF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CHIZF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $14.36B | $16.51B | $18.12B | $14.30B | $19.05B |
| Cost of Revenue | $7.46B | $8.65B | $8.85B | $7.11B | $7.22B |
| Gross Profit | $6.91B | $7.86B | $9.27B | $7.20B | $11.83B |
| Gross Margin %(computed) | 48.09% | 47.59% | 51.18% | 50.32% | 62.09% |
| Operating Expenses | |||||
| R&D Expenses | $0.50B | $0.60B | $0.69B | $0.61B | $0.69B |
| G&A Expenses | $0.00B | $1.06B | $1.04B | $0.94B | $0.97B |
| Total Operating Expenses | $6.61B | $7.52B | $7.85B | $6.13B | $9.12B |
| Operating Income | $0.30B | $0.34B | $1.43B | $1.06B | $2.75B |
| Operating Margin %(computed) | 2.07% | 2.03% | 7.88% | 7.44% | 14.45% |
| Interest Income | $0.03B | $0.05B | $0.07B | $0.07B | $0.06B |
| Interest Expense | $0.10B | $0.24B | $0.20B | $0.22B | $0.22B |
| Income Before Tax | ($0.36B) | $0.16B | $1.22B | $0.84B | $2.52B |
| Income Tax Expense | $0.09B | $0.14B | ($0.17B) | $0.12B | $0.40B |
| Net Income | ($0.33B) | $0.05B | $1.29B | $0.76B | $1.93B |
| Net Margin %(computed) | -2.32% | 0.33% | 7.09% | 5.34% | 10.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $0.01 | $0.26 | $0.15 | $0.38 |
| Wtd Avg Shares | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B |
| EBITDA | $1.40B | $1.53B | $2.56B | $2.16B | $3.59B |
| EBITDA Margin %(computed) | 9.74% | 9.26% | 14.11% | 15.10% | 18.85% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CNY · B
深入了解China Traditional Chinese Medicine Holdings Co. Limited
关于China Traditional Chinese Medicine Holdings Co. Limited（CHIZF）损益表
China Traditional Chinese Medicine Holdings Co. Limited（CHIZF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CHIZF实现营收$14.36B，毛利润$6.91B（毛利率48.09%），净利润($0.33B)（净利率-2.32%）。
常见问题
CHIZF · 4 问China Traditional Chinese Medicine Holdings Co. Limited（CHIZF）2025财年营收为$14.36B，同比down13.0%。
CHIZF revenueCHIZF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08